Skip to content

Citicoline, Creatine, and Omega-3 Effects in Middle Age Women

Citicoline, Creatine, and Omega-3 Effects in Middle Age Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01502813
Enrollment
40
Registered
2012-01-02
Start date
2012-02-01
Completion date
2019-11-01
Last updated
2021-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Benefits

Keywords

Neuropsychological testing, Dietary supplements

Brief summary

The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiatric adult female participants.

Detailed description

Standard clinical measures for mood and neuropsychological measures of attention, cognitive inhibition and memory will be applied before, during, and after a course of a daily supplementation of citicoline, creatine and omega-3 for 28 days to non-psychiatric adult female participants. We hypothesis that the combination of supplements will improve memory and attention in healthy adult women.

Interventions

DRUGCiticoline, Omega-3 Fatty Acids and Creatine

Citicoline: 500 mg/day for 28 days Omega-3 Fatty Acids: 2 g/day for 28 days Creatine: 5 g/day for 28 days

Sponsors

Deborah Yurgelun-Todd
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Female * Age 40-60 years

Exclusion criteria

* Significant medical condition * History of co-morbid psychiatric disorders * Current Axis I or II diagnosis * Past participation in a pharmacotherapeutic trial * Head injury with LOC\>5 minutes * Use of psychotropic medication * History of fish allergies * Medical condition associated with clinically significant decreases in coagulability * Use of anticoagulant medication

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in California Verbal Learning Test (CVLT) That Measure Attention and Memory at 14 DaysBaseline and 14 days from baselineList B in the California Verbal Learning Test (CVLT) score range 1-16; the score is the number of words recalled so higher scores = better performance/more words recalled.
Change From Baseline in WAIS-IV Block Design Subtest A That Measures Attention and Memory at 28 DaysBaseline and 28 days from baselineWAIS-IV Block Design Subtest A test of visuoconstructional ability is recognized as a test of visuospatial planning and function. It has been shown to be correlated with measures of general intellectual ability. The score range for this measure is 0-129. A score of 90-110 is average for a standard score. The higher the score the better the outcome.

Countries

United States

Participant flow

Participants by arm

ArmCount
Citicoline, Creatine, and Omega-3 Arm
Citicoline, Omega-3 Fatty Acids and Creatine: Citicoline: 500 mg/day for 28 days Omega-3 Fatty Acids: 2 g/day for 28 days Creatine: 5 g/day for 28 days
40
Total40

Baseline characteristics

CharacteristicCiticoline, Creatine, and Omega-3 Arm
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
40 Participants
Age, Continuous48.3 years
Analyzed participants40 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
40 Participants
Region of Enrollment
United States
40 participants
Sex: Female, Male
Female
40 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 40
other
Total, other adverse events
0 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

Primary

Change From Baseline in California Verbal Learning Test (CVLT) That Measure Attention and Memory at 14 Days

List B in the California Verbal Learning Test (CVLT) score range 1-16; the score is the number of words recalled so higher scores = better performance/more words recalled.

Time frame: Baseline and 14 days from baseline

ArmMeasureValue (MEDIAN)
Citicoline, Creatine, and Omega-3 ArmChange From Baseline in California Verbal Learning Test (CVLT) That Measure Attention and Memory at 14 Days10 score on a scale
Primary

Change From Baseline in WAIS-IV Block Design Subtest A That Measures Attention and Memory at 28 Days

WAIS-IV Block Design Subtest A test of visuoconstructional ability is recognized as a test of visuospatial planning and function. It has been shown to be correlated with measures of general intellectual ability. The score range for this measure is 0-129. A score of 90-110 is average for a standard score. The higher the score the better the outcome.

Time frame: Baseline and 28 days from baseline

ArmMeasureValue (MEAN)
Citicoline, Creatine, and Omega-3 ArmChange From Baseline in WAIS-IV Block Design Subtest A That Measures Attention and Memory at 28 Days98 Score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026